Home > National Drug Code (NDC) > Triamterene and Hydrochlorothiazide

Triamterene and Hydrochlorothiazide - 0378-1355-05 - (Triamterene and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Triamterene and Hydrochlorothiazide

Product NDC: 0378-1355
Proprietary Name: Triamterene and Hydrochlorothiazide
Non Proprietary Name: Triamterene and Hydrochlorothiazide
Active Ingredient(s): 50; 75    mg/1; mg/1 & nbsp;   Triamterene and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Triamterene and Hydrochlorothiazide

Product NDC: 0378-1355
Labeler Name: Mylan Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA019129
Marketing Category: NDA
Start Marketing Date: 20110209

Package Information of Triamterene and Hydrochlorothiazide

Package NDC: 0378-1355-05
Package Description: 500 TABLET in 1 BOTTLE, PLASTIC (0378-1355-05)

NDC Information of Triamterene and Hydrochlorothiazide

NDC Code 0378-1355-05
Proprietary Name Triamterene and Hydrochlorothiazide
Package Description 500 TABLET in 1 BOTTLE, PLASTIC (0378-1355-05)
Product NDC 0378-1355
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Triamterene and Hydrochlorothiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20110209
Marketing Category Name NDA
Labeler Name Mylan Pharmaceuticals Inc.
Substance Name HYDROCHLOROTHIAZIDE; TRIAMTERENE
Strength Number 50; 75
Strength Unit mg/1; mg/1
Pharmaceutical Classes Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Triamterene and Hydrochlorothiazide


General Information